Skip to main content Skip to main navigation menu Skip to site footer

Fetal Sex Determination Using Cell-Free Fetal Dna (cffDNA) in Maternal Blood



Abstract

Background: Prenatal test has routinely performed in antenatal care and has become a part of the obstetric care feature in many countries. Prenatal test is divided into screening and diagnostic test. Recently, the early noninvasive method in order to found and lessen the risk factors of pregnancy loss, has been studied. One of the methods is molecular test using cffDNA which has many screening purpose such as sex determination, aneuploidy, paternal inherited genetic disorder, fetus rhesus, and performed early at 7 weeks of pregnancy. Objective: The purpose of this study is to measure diagnostic value of cffDNA in determining fetal sex prenatally. Methods: In a diagnostic test study, 18 randomized samples were selected and divided based on fetal gender confirmed at birth. The group consisted of 9 pregnant women with male babies and 9 pregnant women with female babies. CffDNA then isolated from maternal blood sample and specific region in Y chromosome termed SRY is detected by PCR and electrophoresis. The data obtained analyzed both descriptively for baseline characteristic and analytically to determine its diagnostic value. Results: This study found significant correlation between SRY detection in cffDNA with male fetal phenotype (p<0.05). The sensitivity of the method is 100% with 89% specificity. In addition, we found 9.09 values for positive likelihood ratio (LR+) and 0 for negative likelihood ratio (LR-). Moreover, the result yielded 100% positive predictive value (PPV+) and 88.8% of negative predictive value (PPV-). Conclusion: This study proofed that cffDNA have a great diagnostic value to determine fetal sex prenatally. However, further study with several group of gestational age mother and better matching is required to further confirm the diagnostic potential of cffDNA

 

Keywords: cffDNA Fetal Maternal.

References

  1. George SM. Millions of missing girls: from fetal sexing to high technology sex selection in India. Prenat Diagn. 2006; 26:604-609.
  2. Adeyinka AO, Agunloye AM, Idris S. Ultrasonographic assessment of fetal gender. Afr J Med Med Sci. 2005 Dec;34(4):345-8.
  3. Alfirevic Z, Mujezinovic F, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database System 2003; Rev issue 3, Art No CD003252.
  4. Bianchi DW. Circulating Fetal DNA: Its Origin and Diagnostic Potential—A Review. Placenta 25, Supplement A, Trophoblast Research,2004; (18): S93–S101.
  5. Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350:485–487
  6. Wright CF and Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update 2009;15(1): 139–151
  7. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T Et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002; 110:75–9.
  8. Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet.2011;80(1):68-75.
  9. Sastoasmoro S, Ismael S. “Dasar-dasar Metodologi Penelitian Klinis†Edisi 4: 2011.
  10. Settin A, Elsobsky E, Hammad A, Al-Erany A. Rapid Sex Determination Using PCR Technique Compared to Classic Cytogenetics. Int J Health Sci 2008;2(1): 49–52
  11. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive Fetal Sex Determination Using Cell-Free Fetal DNA. JAMA. 2011; 306(6): 627–636
  12. Zargari M, Sadeghi MR, Shahhosseiny MH, et.al. Fetal Sex Determination using Non-Invasive Method of Cell-free Fetal DNA in Maternal Plasma of Pregnant Women During 6th– 10th Weeks of Gestation. Avicenna J Med Biotechnol. 2011; 3(4): 201–206
  13. Scheffer PG, van der Schoot CE, Page-Christiaens GC, et al. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol. 2010;115(1):117–126

How to Cite

Sanjaya, I. N. H., Suwardewa, T. G. A., & Arijana, I. G. K. N. (2016). Fetal Sex Determination Using Cell-Free Fetal Dna (cffDNA) in Maternal Blood. Bali Medical Journal, 5(2), 272–274. https://doi.org/10.15562/bmj.v5i2.197
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
85

Total
2

Share

Search Panel

I Nyoman Hariyasa Sanjaya
Google Scholar
Pubmed
BMJ Journal

Tjok Gde Agung Suwardewa
Google Scholar
Pubmed
BMJ Journal

I G Kamasan N. Arijana
Google Scholar
Pubmed
BMJ Journal